Int J Pediatr Adolesc Med
June 2022
Background: Internationally, Cystic fibrosis-associated liver disease (CFLD) is considered the third leading cause of death, following lung disease and transplantation complications.
Aims: To identify the prevalence of CFLD in cystic fibrosis (CF) patients.
Methodology: A retrospective chart review for all patients with CF liver disease from a tertiary care center.